History
  • No items yet
midpage
AstraZeneca AB v. United Food & Commercial Workers Unions
777 F.3d 9
| 1st Cir. | 2015
Read the full case

Background

  • AstraZeneca marketed Nexium and settled separate Hatch-Waxman paragraph IV suits with Ranbaxy, Teva, and DRL by paying them and obtaining agreements delaying generic entry until main patents expired in 2014 (so-called reverse payments).
  • Named plaintiffs are third-party payors (TPPs) and consumers who allege the settlements unlawfully foreclosed competition, caused supra-competitive Nexium prices from April 14, 2008 to May 27, 2014, and seek a Rule 23(b)(3) damages class.
  • The district court certified a nationwide class of purchasers of Nexium (with defined exceptions) despite acknowledging that some class members might be uninjured; defendants appealed under Rule 23(f).
  • Plaintiffs’ liability theory relies on Actavis and a rule-of-reason antitrust challenge to reverse-payment settlements; plaintiffs’ damages expert estimated but-for prices using a yardstick (Prevacid) to model generic pricing.
  • Defendants argued certification failed because the class includes a (they contend substantial) number of uninjured members (brand‑loyalists, coupon users, certain TPP-plan structures, etc.), which would defeat predominance and defeat administrability and Article III standing for unnamed class members.
  • The First Circuit affirmed, holding a class may include a de minimis number of uninjured members so long as (1) the class is definite/ascertainable, (2) aggregate recovery can be limited to actual injury, and (3) a feasible, protective mechanism exists to exclude uninjured members prior to judgment.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether a Rule 23(b)(3) class may include some uninjured members A class may include a de minimis number of uninjured members; individualized culling can occur later Any uninjured members (even de minimis) defeat predominance because common proof cannot establish fact of injury for all A class may include a de minimis number of potentially uninjured members; presence of such members does not automatically defeat certification
Whether plaintiffs met predominance with common proof of antitrust impact and damages Rosenthal's yardstick model shows widespread overcharge and common proof of impact for vast majority Defendants’ expert identifies five groups likely uninjured, undermining common proof and predominance District court did not abuse discretion; plaintiffs met burden and defendants failed to show more-than-de minimis uninjured group
Whether an administratively feasible mechanism exists to exclude uninjured members before judgment Injured vs. uninjured can be sorted later by presumptions or affidavits/testimony; Rule 23 does not demand final sorting at certification No specific workable method has been proposed; class-wide affidavits would be unworkable and may violate defendants’ rights Court held it was sufficient that a feasible mechanism could be developed later and defendants’ speculation that none could be was insufficient to deny certification
Article III standing for the class Named plaintiffs suffered injury and have standing; unnamed members need not each show standing at certification so long as injured representatives exist Because some class members lack injury, class-wide standing is deficient Named plaintiffs’ standing suffices for certification; only injured class members will recover and standing for individual recoverants will be ensured before payment

Key Cases Cited

  • FTC v. Actavis, 133 S. Ct. 2223 (2013) (reverse-payment settlements evaluated under rule-of-reason antitrust analysis)
  • Comcast Corp. v. Behrend, 133 S. Ct. 1426 (2013) (damages model must measure damages tied to the asserted theory of liability to satisfy Rule 23(b)(3))
  • Wal-Mart Stores, Inc. v. Dukes, 131 S. Ct. 2541 (2011) (Rule 23(a) commonality requirement and limits on merits inquiry at certification)
  • Amgen Inc. v. Connecticut Retirement Plans, 133 S. Ct. 1184 (2013) (class certification does not require proving each element on a classwide basis; rigorous analysis limits merits probing)
  • Halliburton Co. v. Erica P. John Fund, 134 S. Ct. 2398 (2014) (presumptions may be used at certification and individualized rebuttal does not necessarily defeat predominance)
  • Illinois Brick Co. v. Illinois, 431 U.S. 720 (1977) (federal rule barring indirect-purchaser antitrust damages suits; background for state-law indirect purchaser claims)
  • Messner v. Northshore Univ. HealthSystem, 669 F.3d 802 (7th Cir. 2012) (small percentage reductions in class size from removing uninjured members may not defeat certification)
  • In re New Motor Vehicles Canadian Export Antitrust Litig., 522 F.3d 6 (1st Cir. 2008) (plaintiffs must show at certification that their model can preliminarily identify which consumers were impacted)
Read the full case

Case Details

Case Name: AstraZeneca AB v. United Food & Commercial Workers Unions
Court Name: Court of Appeals for the First Circuit
Date Published: Jan 21, 2015
Citation: 777 F.3d 9
Docket Number: Nos. 14-1521, 14-1522
Court Abbreviation: 1st Cir.